The pipine looks exceptional. Poised to deliver to people in need of advanced pharmaceutical solutions in the focused areas. Excellent work by all and especially the executive team with research & development.
Adam, thank you for swift pat on the back! Thank the stupid shareholders too that paid for the pipeline with the purchase of Celgene. We were desperate and paid for a bunch of stuff that will never net out $70B plus. Stock is still not a buy. Signed, F'ed at BMS
Seriously, what's wrong with our pipeline in it's entirety? I think the executive leadership and research has done an exceptional job as we move further into this decade.
Great leadership that wisely is pivoting away from the “All IO Strategy” Look for thinks to kick into high gear a year from now....
Exactly. The all IO was very unwise and an all eggs in one basket approach. I suspect that was a Tom Lynch approach? Now there is huge potential in at least three different therapeutic areas. GC is killing it.
Knowledgeable, positive outlooks! I hope we do it with class and compassion as we help others deal with deadly disease.
Sorry but the All IO approach was not Tom’s decision, the foundation was laid before he arrived in 2017.
It is one thing to have a strong pipeline. It is another to have the intellectual horsepower to gain FDA approval. BMS possesses none of the above. Call it a pipedream.
